دورية أكاديمية

842TiP - A multicentre, international, randomised, open-label phase 3 trial of avelumab + best supportive care (BSC) vs BSC alone as maintenance therapy after first-line platinum-based chemotherapy in patients with advanced urothelial cancer (JAVELIN bladder 100)

التفاصيل البيبلوغرافية
العنوان: 842TiP - A multicentre, international, randomised, open-label phase 3 trial of avelumab + best supportive care (BSC) vs BSC alone as maintenance therapy after first-line platinum-based chemotherapy in patients with advanced urothelial cancer (JAVELIN bladder 100)
المؤلفون: Powles, T., Grivas, P., Aragon-Ching, J.B., Faroun, Y., Kessler, E.R., Tomita, Y., Chakrabarti, D., Laliberte, R.J., Shnaidman, M., Petrylak, D.
المصدر: In Annals of Oncology 1 October 2016 27 Supplement 6:vi292-vi292
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw373.69